1. Home
  2. TRTX vs RLMD Comparison

TRTX vs RLMD Comparison

Compare TRTX & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TPG RE Finance Trust Inc.

TRTX

TPG RE Finance Trust Inc.

HOLD

Current Price

$8.40

Market Cap

659.4M

Sector

Real Estate

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$6.35

Market Cap

661.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRTX
RLMD
Founded
2014
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
659.4M
661.9M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
TRTX
RLMD
Price
$8.40
$6.35
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$9.83
$12.40
AVG Volume (30 Days)
698.7K
2.3M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
11.55%
N/A
EPS Growth
N/A
45.28
EPS
N/A
N/A
Revenue
N/A
$13,070.00
Revenue This Year
$8.78
N/A
Revenue Next Year
$4.14
N/A
P/E Ratio
$14.82
N/A
Revenue Growth
N/A
154.83
52 Week Low
$7.57
$0.55
52 Week High
$9.85
$8.00

Technical Indicators

Market Signals
Indicator
TRTX
RLMD
Relative Strength Index (RSI) 46.79 42.80
Support Level $8.35 $6.17
Resistance Level $8.72 $7.34
Average True Range (ATR) 0.15 0.45
MACD -0.02 0.01
Stochastic Oscillator 30.61 1.75

Price Performance

Historical Comparison
TRTX
RLMD

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: